Answer
Itraconazole increases ivacaftor exposure 4.3-fold without affecting lumacaftor exposure in Orkambi; no dose adjustment is necessary when itraconazole is started during established Orkambi treatment, but Orkambi dosing should be adjusted when it is started in patients already taking itraconazole.
Sources for this answer
- Orkambi 200 mg/125 mg film coated tabletsVertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 19Document updated
Sources checked